Cargando…
Andrographolide inhibits non-small cell lung cancer cell proliferation through the activation of the mitochondrial apoptosis pathway and by reprogramming host glucose metabolism
BACKGROUND: The main aim of this research was to explore the role and mechanism of Andrographolide (Andro) in controlling non-small cell lung cancer (NSCLC) cell proliferation. METHODS: Human NSCLC H1975 cells were treated with Andro (0–20 µM) for 4–72 h. B-cell leukemia/lymphoma 2 (Bcl-2)-antagonis...
Autores principales: | Chen, Zhao, Tang, Wei-Jian, Zhou, Yu-Han, Chen, Zhou-Miao, Liu, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667159/ https://www.ncbi.nlm.nih.gov/pubmed/34988210 http://dx.doi.org/10.21037/atm-21-5975 |
Ejemplares similares
-
Glucose Metabolic Reprogramming and Cell Proliferation Arrest in Colorectal Micropapillary Carcinoma
por: Vyas, Monika, et al.
Publicado: (2019) -
Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells
por: Mayengbam, Shyamananda Singh, et al.
Publicado: (2023) -
Andrographolide Suppresses Proliferation of Nasopharyngeal Carcinoma Cells via Attenuating NF-κB Pathway
por: Peng, Tao, et al.
Publicado: (2015) -
Andrographolide sensitizes prostate cancer cells to TRAIL-induced apoptosis
por: Wei, Ruo-Jing, et al.
Publicado: (2018) -
Andrographolide induces apoptosis in human osteosarcoma cells via the ROS/JNK pathway
por: Wang, Shengdong, et al.
Publicado: (2020)